Growth Metrics

Nephros (NEPH) Accumulated Expenses (2010 - 2026)

Nephros' quarterly Accumulated Expenses came in at $662000.0 in Q1 2026, up 9.78% year-on-year from $603000.0 in Q1 2025, and down 54.72% quarter-over-quarter from $1.5 million in Q4 2025.

Nephros has reported Accumulated Expenses for 17 years, with the latest figure at $662000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Accumulated Expenses rose 9.78% year-over-year to $662000.0; the trailing twelve-month figure through Mar 2026 stood at $662000.0 (up 9.78% YoY), and the FY2025 full-year result was $1.5 million, up 599.52% from the prior year.
  • Accumulated Expenses for Q1 2026 stood at $662000.0, down from $1.5 million in the prior quarter.
  • The five-year high for Accumulated Expenses was $1.5 million in Q4 2025, with the low at $185000.0 in Q2 2022.
  • Average Accumulated Expenses over 5 years is $543352.9, with a median of $435000.0 recorded in 2024.
  • Year-over-year, Accumulated Expenses slumped 61.13% in 2022 and surged 599.52% in 2025.
  • Tracing NEPH's Accumulated Expenses over 5 years: stood at $285000.0 in 2022, then soared by 88.42% to $537000.0 in 2023, then sank by 61.08% to $209000.0 in 2024, then surged by 599.52% to $1.5 million in 2025, then tumbled by 54.72% to $662000.0 in 2026.
  • The last three Accumulated Expenses figures came in at $662000.0 (Q1 2026), $1.5 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Nephros 38.93 Mn 34.91 Mn 2.99 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 662,000.00
Dec 31, 2025 1.46 Mn
Sep 30, 2025 1.15 Mn
Jun 30, 2025 771,000.00
Mar 31, 2025 603,000.00
Dec 31, 2024 209,000.00
Sep 30, 2024 322,000.00
Jun 30, 2024 435,000.00
Mar 31, 2024 413,000.00
Dec 31, 2023 537,000.00
Sep 30, 2023 712,000.00
Jun 30, 2023 572,000.00
Mar 31, 2023 383,000.00
Dec 31, 2022 285,000.00
Sep 30, 2022 272,000.00
Jun 30, 2022 185,000.00
Mar 31, 2022 263,000.00
Dec 31, 2021 444,000.00
Sep 30, 2021 573,000.00
Jun 30, 2021 476,000.00
Mar 31, 2021 72,000.00
Dec 31, 2020 24,000.00
Sep 30, 2020 596,000.00
Jun 30, 2020 449,000.00
Mar 31, 2020 308,000.00
Dec 31, 2019 50,000.00
Sep 30, 2019 715,000.00
Jun 30, 2019 601,000.00
Mar 31, 2019 512,000.00
Dec 31, 2018 42,000.00
Sep 30, 2018 524,000.00
Jun 30, 2018 377,000.00
Mar 31, 2018 29,000.00
Dec 31, 2017 218,000.00
Sep 30, 2017 7,000.00
Jun 30, 2017 22,000.00
Mar 31, 2017 19,000.00
Dec 31, 2016 19,000.00
Sep 30, 2016 10,000.00
Jun 30, 2016 14,000.00
Mar 31, 2016 15,000.00
Dec 31, 2015 237,000.00
Sep 30, 2015 154,000.00
Jun 30, 2015 306,000.00
Mar 31, 2015 432,000.00
Dec 31, 2014 50,000.00
Sep 30, 2014 300,000.00
Jun 30, 2014 233,000.00
Mar 31, 2014 194,000.00
Dec 31, 2013 365,000.00
Sep 30, 2013 183,000.00
Jun 30, 2013 200,000.00
Mar 31, 2013 507,000.00
Dec 31, 2012 321,000.00
Sep 30, 2012 179,000.00
Jun 30, 2012 170,000.00
Mar 31, 2012 132,000.00
Dec 31, 2011 195,000.00
Sep 30, 2011 105,000.00
Jun 30, 2011 102,000.00
Dec 31, 2010 481,000.00